News & Stories Health Care Production of cheaper alternatives to name brand obesity drugs will stop on Wednesday Sydney Lupkin March 18, 2025 / 2:29 pm Play AudioPlaying4 mins left Large-scale compounding facilities have to stop making tirzepatide, the main ingredient in blockbuster obesity drug Zepbound, Wednesday. Why you can trust KUOW Recommended Stories Trump cuts could leave 250,000 Washingtonians without health coverage, shutter rural hospitals July 18, 2025 Washington prepares for end of 988 crisis line support tailored to LGBTQ+ youth July 17, 2025 A Seattle doctor was investigated for fertility fraud. The case highlights tension between patient, physician rights April 03, 2025
Trump cuts could leave 250,000 Washingtonians without health coverage, shutter rural hospitals July 18, 2025
A Seattle doctor was investigated for fertility fraud. The case highlights tension between patient, physician rights April 03, 2025